Additionally, the CKI genes hypermethylation has also been reported to be a frequent process in the progression of AdCC, whereas HCN2 hypomethylation has been reported to be the possible biomarker that point out the more aggressive form of AdCC. Here, HCN2 is linked to adrenocortical carcinoma, hereditary.